1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 16 NOVEMBER 2015

Cancer Drug News 16 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Early Companion Diagnostic Implementation To Rise
Industry Brief - Immunomedics' Sacituzumab Govitecan Improves PFS In Phase II TNBC Study
Industry Brief - AbbVie Submits Imbruvica Phase III Combination Data To FDA
Industry Trend Analysis - Tagrisso Will Take Market Share With Accelerated Approval
Industry Trend Analysis - Boston Scientific To Target Liver Cancer In Emerging Markets
Industry Brief - Transgene/SillaJen Revise Pexa-Vec Agreement
Industry Brief - Array/Pierre Fabre To Co-Develop Binimetinib And Encorafenib
Industry Trend Analysis - Cotellic/Zelboraf Potential Lies Beyond Melanoma
Industry Brief - BIND's Accurin Platform Shown To Improve Efficacy/Tolerability Of Multiple Anticancer Agents
Industry Brief - ArQule Presents Positive Data From Proprietary Oncology Pipeline
Industry Trend Analysis - PoC Testing Expands Reach
Industry Trend Analysis - Growing Cancer Burden To Provide Revenue Earning Opportunities
Industry Trend Analysis - Deep Pipeline Shifts Driving Industry-Wide Manufacturing Network Changes

Table Of Contents

Cancer Drug News 16 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


Download Unlimited Documents from Trusted Public Sources

Endocrine Disease Statistics in the US

  • February 2017
    115 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Hormone and Therapy Market in Pakistan and the US

  • February 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Cancer Statistics in the UK

  • February 2017
    15 pages
  • Cancer  

  • United Kingdom  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.